Richardson Peter C 4
4 · ANTARES PHARMA, INC. · Filed Apr 28, 2021
Insider Transaction Report
Form 4
Richardson Peter C
EVP, R&D Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-04-26+59,179→ 59,179 totalExercise: $4.01Exp: 2031-04-26→ Common Stock (59,179 underlying)
Footnotes (2)
- [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F2]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.